Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Defra permits licensed use of bluetongue vaccines
Movement restrictions will still apply to vaccinated animals.
The unauthorised vaccines are expected to lessen symptoms.

The use of three unauthorised vaccines for bluetongue virus serotype 3 (BTV-3) will be permitted in the UK subject to licence, the Department for Environment, Food and Rural Affairs (Defra) has announced.

The three vaccines permitted for use are Bultavo-3, BLUEVAC-3, and Syvazul BTV3. All three have been used in other European countries.

The vaccines are not expected to prevent animals from being infected by the virus or spreading it to other animals. However, the vaccines claim to reduce or prevent the clinic signs of bluetongue.

Because vaccinated animals will still be infectious, movement and trade restrictions will still apply to them.

It is expected that licences will become available in the coming days. The vaccines will have to be prescribed by a veterinary surgeon.

New cases of BTV-3 continue to be confirmed in England. In addition to recent cases in Norfolk and Suffolk, a case was confirmed at premises near Withersea in the East Riding of Yorkshire on 4 September. A 20km temporary control zone has been put in place and the affected animal will be culled.

A restricted zone is currently in place Essex, Suffolk, and Norfolk. A specific licence is required to move animals outside the zone and farmers are urged to only move animals within the zone when it’s absolutely essential.

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office.

More information on the vaccine permits is available here. Further information on the restrictions can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.